Pharma Pulse 4/18/25: Bringing Biotech Innovation Across Borders, Role of Collaboration in Advancing Rare Disease Research
Bringing Biotech Innovation Across Borders
A feature published by Pharmaceutical Executive authored by Ed Ahn, CEO of MEDIPOST, Inc, outlines four tips for midsized companies when entering new global markets.
The Role of Collaboration in Advancing Rare Disease Research
In this video interview published by Applied Clinical Trials, Derek Ansel, vice president, therapeutic strategy lead, rare disease, Worldwide Clinical Trials, discusses collaboration and maximizing resources among the various stakeholders in rare disease research.
Mark Cuban’s drug firm targets injectable shortages
Mark Cuban’s Cost Plus Drug Company has partnered with distributor Morris & Dickson to address nationwide injectable drug shortages by streamlining procurement and enhancing access for healthcare providers.
Bayer has invested $44 million to expand its Myerstown, PA manufacturing facility, enhancing production capabilities, workforce development, and community engagement as part of its commitment to delivering trusted self-care products across North America.
First meeting of CDC vaccine advisers under RFK Jr. is mostly 'business as usual'
Despite concerns over political interference and resource cuts, the CDC’s vaccine advisory committee held its first meeting under HHS Secretary RFK Jr. with routine deliberations and evidence-based decisions, though funding shortfalls and leadership changes raised questions about future public health capacity.
Have news you want us to share in Pharma Pulse? Reach out to Associate Editor Don Tracy. He can be reached at [email protected]
